<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OCTOBER 30, 1998
- --------------------------------------------------------------------------------
(Date of Report)
SPACELABS MEDICAL, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 0-20083 91-1558809
- ---------------- ---------------------- -------------------
(State or other Commission File Number (I.R.S. Employer
jurisdiction of Identification No.)
incorporation or
organization)
15220 N.E. 40TH STREET
REDMOND, WASHINGTON 98073
- ---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
(425) 882-3700
- --------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
<PAGE> 2
ITEM 8. CHANGE IN FISCAL YEAR
On October 30, 1998, the Company's Board of Directors approved a change in
the Company's fiscal year end from a 52-53 week year ending the last Friday in
December to a December 31 year end. The transition period from December 26, 1998
to December 31, 1998 will be included in the Company's Annual Report on Form
10-K for the year ending December 31, 1998.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of Section 13 or Section 15(d) the Securities and
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
SPACELABS MEDICAL, INC.
-----------------------------------
(Registrant)
Dated: November 9, 1998 By /s/ Carl A. Lombardi
----------------------------------
Carl A. Lombardi
Chairman of the Board
